Below is Validea's guru fundamental report for TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) (TEVA). Of the 22 guru strategies we follow, TEVA rates highest using our Acquirer's Multiple Investor model ...
Hosted on MSN26d
Teva to divest API unit to focus on core business strengthsTeva (NYSE:TEVA) plans to divest its active-pharmaceutical ingredient (API) business as part of its Pivot to Growth strategy to focus on its core business strengths.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback